Vycor Medical, Inc. VYCO
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 26.11% | 88.01% | 32.31% | 91.47% | 56.25% |
| Total Depreciation and Amortization | -2.51% | -2.64% | -1.25% | 2.90% | 3.41% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -58.50% | 4.34% | 71.71% | 395.07% | 387.80% |
| Change in Net Operating Assets | 168.32% | -49.01% | -177.23% | -194.43% | -126.58% |
| Cash from Operations | 858.02% | 260.38% | -122.46% | -187.58% | -110.32% |
| Capital Expenditure | 82.22% | 3.70% | 3.70% | 68.14% | 4.26% |
| Sale of Property, Plant, and Equipment | 84.62% | 480.00% | -33.33% | 0.00% | 550.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 110.53% | 52.08% | -7.32% | 74.51% | 17.39% |
| Total Debt Issued | -3.28% | -3.28% | -3.28% | -0.51% | -0.65% |
| Total Debt Repaid | 4.31% | 18.78% | 12.68% | 8.54% | 0.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 23.08% | 121.51% | 89.47% | 103.92% | -11.43% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 402.55% | 559.06% | -138.51% | -205.54% | -129.74% |